225 related articles for article (PubMed ID: 33658705)
1. FIH-1-modulated HIF-1α C-TAD promotes acute kidney injury to chronic kidney disease progression via regulating KLF5 signaling.
Li ZL; Wang B; Lv LL; Tang TT; Wen Y; Cao JY; Zhu XX; Feng ST; Crowley SD; Liu BC
Acta Pharmacol Sin; 2021 Dec; 42(12):2106-2119. PubMed ID: 33658705
[TBL] [Abstract][Full Text] [Related]
2. HIF-1α participates in the regulation of S100A16-HRD1-GSK3β/CK1α pathway in renal hypoxia injury.
Han S; Jin R; Huo L; Teng Y; Zhao L; Zhang K; Li R; Su D; Liang X
Cell Death Dis; 2024 May; 15(5):316. PubMed ID: 38710691
[TBL] [Abstract][Full Text] [Related]
3. HIF-1α is transcriptionally regulated by NF-κB in acute kidney injury.
Li ZL; Ji JL; Wen Y; Cao JY; Kharbuja N; Ni WJ; Yin D; Feng ST; Liu H; Lv LL; Liu BC; Wang B
Am J Physiol Renal Physiol; 2021 Aug; 321(2):F225-F235. PubMed ID: 34229478
[TBL] [Abstract][Full Text] [Related]
4. KLF4 initiates sustained YAP activation to promote renal fibrosis in mice after ischemia-reperfusion kidney injury.
Xu D; Chen PP; Zheng PQ; Yin F; Cheng Q; Zhou ZL; Xie HY; Li JY; Ni JY; Wang YZ; Chen SJ; Zhou L; Wang XX; Liu J; Zhang W; Lu LM
Acta Pharmacol Sin; 2021 Mar; 42(3):436-450. PubMed ID: 32647339
[TBL] [Abstract][Full Text] [Related]
5. Proximal tubular FHL2, a novel downstream target of hypoxia inducible factor 1, is a protector against ischemic acute kidney injury.
Wang Y; Kuang Z; Xing X; Qiu Y; Zhang J; Shao D; Huang J; Dai C; He W
Cell Mol Life Sci; 2024 May; 81(1):244. PubMed ID: 38814462
[TBL] [Abstract][Full Text] [Related]
6. Anti-anemia drug FG4592 retards the AKI-to-CKD transition by improving vascular regeneration and antioxidative capability.
Wu M; Chen W; Miao M; Jin Q; Zhang S; Bai M; Fan J; Zhang Y; Zhang A; Jia Z; Huang S
Clin Sci (Lond); 2021 Jul; 135(14):1707-1726. PubMed ID: 34255035
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Transactivation at C-TAD Domain of HIF-1
Rani S; Roy S; Singh M; Kaithwas G
Oxid Med Cell Longev; 2022; 2022():2407223. PubMed ID: 35592530
[TBL] [Abstract][Full Text] [Related]
8. Mitophagy mediated by HIF-1α/FUNDC1 signaling in tubular cells protects against renal ischemia/reperfusion injury.
Zhang W; Guo C; Li Y; Wang H; Wang H; Wang Y; Wu T; Wang H; Cheng G; Man J; Chen S; Fu S; Yang L
Ren Fail; 2024 Dec; 46(1):2332492. PubMed ID: 38584135
[TBL] [Abstract][Full Text] [Related]
9. Effects of HIF-1α on renal fibrosis in cisplatin-induced chronic kidney disease.
Zhao H; Han Y; Jiang N; Li C; Yang M; Xiao Y; Wei L; Xiong X; Yang J; Tang C; Xiao L; Liu F; Liu Y; Sun L
Clin Sci (Lond); 2021 May; 135(10):1273-1288. PubMed ID: 33997886
[TBL] [Abstract][Full Text] [Related]
10. Evolution of hypoxia and hypoxia-inducible factor asparaginyl hydroxylase regulation in chronic kidney disease.
Faivre A; Dissard R; Kuo W; Verissimo T; Legouis D; Arnoux G; Heckenmeyer C; Fernandez M; Tihy M; Rajaram RD; Delitsikou V; Le NA; Spingler B; Mueller B; Shulz G; Lindenmeyer M; Cohen C; Rutkowski JM; Moll S; Scholz CC; Kurtcuoglu V; de Seigneux S
Nephrol Dial Transplant; 2023 Sep; 38(10):2276-2288. PubMed ID: 37096392
[TBL] [Abstract][Full Text] [Related]
11. The profibrotic effects of MK-8617 on tubulointerstitial fibrosis mediated by the KLF5 regulating pathway.
Li ZL; Lv LL; Wang B; Tang TT; Feng Y; Cao JY; Jiang LQ; Sun YB; Liu H; Zhang XL; Ma KL; Tang RN; Liu BC
FASEB J; 2019 Nov; 33(11):12630-12643. PubMed ID: 31451021
[TBL] [Abstract][Full Text] [Related]
12. Activation of TGR5 restores AQP2 expression via the HIF pathway in renal ischemia-reperfusion injury.
Han M; Li S; Xie H; Liu Q; Wang A; Hu S; Zhao X; Kong Y; Wang W; Li C
Am J Physiol Renal Physiol; 2021 Mar; 320(3):F308-F321. PubMed ID: 33427060
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factor protects against acute kidney injury via the Wnt/β-catenin signaling pathway.
Xu ZH; Wang C; He YX; Mao XY; Zhang MZ; Hou YP; Li B
Am J Physiol Renal Physiol; 2022 Jun; 322(6):F611-F624. PubMed ID: 35403451
[TBL] [Abstract][Full Text] [Related]
14. Sustained Activation of Wnt/β-Catenin Signaling Drives AKI to CKD Progression.
Xiao L; Zhou D; Tan RJ; Fu H; Zhou L; Hou FF; Liu Y
J Am Soc Nephrol; 2016 Jun; 27(6):1727-40. PubMed ID: 26453613
[TBL] [Abstract][Full Text] [Related]
15. Activation of HIF-1α C-terminal transactivation domain protects against hypoxia-induced kidney injury through hexokinase 2-mediated mitophagy.
Li ZL; Ding L; Ma RX; Zhang Y; Zhang YL; Ni WJ; Tang TT; Wang GH; Wang B; Lv LL; Wu QL; Wen Y; Liu BC
Cell Death Dis; 2023 May; 14(5):339. PubMed ID: 37225700
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of unilateral ischemia-reperfusion injury: importance of renal counterbalance and implications for the AKI-CKD transition.
Polichnowski AJ; Griffin KA; Licea-Vargas H; Lan R; Picken MM; Long J; Williamson GA; Rosenberger C; Mathia S; Venkatachalam MA; Bidani AK
Am J Physiol Renal Physiol; 2020 May; 318(5):F1086-F1099. PubMed ID: 32174143
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-122-5p ameliorates tubular injury in diabetic nephropathy via FIH-1/HIF-1α pathway.
Cheng L; Qiu X; He L; Liu L
Ren Fail; 2022 Dec; 44(1):293-303. PubMed ID: 35166173
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
Gong T; Cui L; Wang H; Wang H; Han N
J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
[TBL] [Abstract][Full Text] [Related]
19. A bioinspired carbon monoxide delivery system prevents acute kidney injury and the progression to chronic kidney disease.
Nagasaki T; Maeda H; Taguchi K; Yanagisawa H; Nishida K; Kobayashi K; Wada N; Noguchi I; Murata R; Sakai H; Kitagishi H; Saruwatari J; Watanabe H; Otagiri M; Maruyama T
Redox Biol; 2022 Aug; 54():102371. PubMed ID: 35763935
[TBL] [Abstract][Full Text] [Related]
20. Cilastatin Preconditioning Attenuates Renal Ischemia-Reperfusion Injury via Hypoxia Inducible Factor-1α Activation.
Hong YA; Jung SY; Yang KJ; Im DS; Jeong KH; Park CW; Hwang HS
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32438631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
